Brain tumors are the most common cancer in children and adolescents ages 0-19 years in the U.S.
Only a few treatments have ever been approved for the more than 100 types of brain tumors. None of these extend survival more than two years on average, or are considered to be curative.
Yet survival rates for pediatric patients with brain tumors have not changed significantly over the past 45 years despite major improvements made in the treatment of other cancers.
For many tumor types, surgery and radiation remain the standard of care, and national guidelines suggest that clinical trials remain the best place to care for patients.
Data obtained from the National Brain Tumor Society.
We are focused on advancing the research, treatment and care of pediatric brain cancer.
We support the development of treatments and clinical trials that traditional research funding doesn’t support.
We aim to reduce the hardship of battling a brain tumor and pave a path to a brighter future for our young patients.
We strive to provide HOPE.
Our Programs
-
Pediatric Brain Cancer Wine Luncheon - April 24, 2025
A wonderful afternoon celebrating patient families, gaining insight into the research program at Duke and raising funds for our mission.
-
Hope for the Holidays
Support families required to stay in the hospital over the holidays. Normalize the effects of prolonged hospital stays and reduce the hardship of battling a brain tumor.